Kinsale Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Kinsale Capital Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-190,863	Closed	-$11.6M	–	42
2026 Q1	$11.6M	Buy	190,863 +11,499	+6%	+$670K	1.86%	17
2025 Q4	$9.67M	Buy	179,364 +10,724	+6%	+$516K	1.61%	25
2025 Q3	$7.61M	Buy	168,640 +18,863	+13%	+$881K	1.39%	32
2025 Q2	$6.93M	Buy	149,777 +17,687	+13%	+$868K	1.42%	30
2025 Q1	$8.06M	Buy	132,090 +20,820	+19%	+$1.21M	1.98%	23
2024 Q4	$6.29M	Buy	111,270 +15,673	+16%	+$876K	1.69%	24
2024 Q3	$4.95M	Buy	95,597 +18,163	+23%	+$852K	1.46%	30
2024 Q2	$3.22M	Buy	77,434 +18,498	+31%	+$828K	1.11%	34
2024 Q1	$3.2M	Buy	58,936 +15,987	+37%	+$814K	1.26%	33
2023 Q4	$2.2M	Buy	42,949 +14,537	+51%	+$763K	1.09%	31
2023 Q3	$1.65M	Buy	28,412 +9,521	+50%	+$583K	0.94%	30
2023 Q2	$1.21M	Buy	18,891 +7,697	+69%	+$516K	0.73%	33
2023 Q1	$776K	Buy	+11,194	New	+$790K	0.57%	26

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Kinsale Capital Group's BMY Position: Q2 2026 in Review

Kinsale Capital Group sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 190,863 shares — an estimated $11.6M sold.

Kinsale Capital Group first reported a position in BMY in Q1 2023 and held it in 13 quarters. The position peaked at $11.6M in Q1 2026. 2,503 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Kinsale Capital Group reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Kinsale Capital Group sold 190,863 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.6M.
Kinsale Capital Group first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 13 quarters.
Kinsale Capital Group's Bristol-Myers Squibb position peaked at $11.6M in Q1 2026.
2,503 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Kinsale Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.